Scientific Programme Scientific Programme Search Abstract

Congress Friday, 22 June 2001 Saturday, 23 June 2001 Sunday, 24 June 2001

Friday, 22 June 2001

12:15-13:15 Harmonie I, Messe Congress Center Cure of CML is possible without SCT Chair(s) R. Foa (Rome, Italy)

12:15-13:15 Harmonie II, Messe Congress Center Allo Transplantation in chronic lymphocytic Leukemia Chair(s) C. Binet (Tours Cedex, France)

12:15-13:15 Spektrum I-II, Messe Congress Centre Are Plasma derived Factor VIII concentrates obsolete? Chair(s) J. Vermylen (Leuven, Belgium)

17:00-18:30 CMPE: Biology and Diagnosis

17:00-18:30 CMPE: Treatment and Outcome

17:00-18:30 CML: Diagnosis and Biology

17:00-18:30 CML: Treatment and Prognosis

17:00-18:30 STI571: Biology and Treatment Results

17:00-18:30 Myeloma: Biology

17:00-18:30 Myeloma: Diagnosis and Staging

17:00-18:30 Myeloma: Treatment

17:00-18:30 Myeloma: Thalidomide

17:00-18:30 Myeloma: Prognostic factors and Clinical Course

17:00-18:30 CLL: Biology and Molecular Genetics

17:00-18:30 CLL: Clinical Characteristics and Diagnosis

17:00-18:30 CLL: Treatment

17:00-18:30 CLL: Prognosis and Clinical Course

17:00-18:30 Red Cell Disorders: Thalassaemia

17:00-18:30 Red Cell Disorders: congenital red Cell Disorders

17:00-18:30 Red Cell Disorders: Anaemias

17:00-18:30 Red Cell Disorders: Erythropoetin Treatment

17:00-18:30 Red Cell Disorders: Iron Metabolism

17:00-18:30 Epidemiology/Quality of Life/Evidence based Medicine

17:00-18:30 Hematology related Diseases

17:00-18:30 Molecular targeting and Gene Therapy

17:00-18:30 Gene regulation, Cell Cycle and Apoptosis

17:00-18:30 Cytokines, Growth Factors and Receptors

17:00-18:30 Drug resistance and Chemosensitivity

Saturday, 23 June 2001

08:30-10:00 Harmonie I, Messe Congress Center Stem Cell Transplantation: Reduced Intensity conditioning regimens Chair(s) D. Niederwieser (Leipzig, Germany) , A.M. Carella (Genova, Italy)

08:30-10:15 Harmonie II, Messe Congress Center Latest update of clinical trials in Multiple Myeloma Chair(s) H. Goldschmidt (Heidelberg, Germany) , J-L. Harousseau (Nantes - Cedex, France)

08:30-10:00 Westendhalle I, Marriott Hotel AML: Biology and prognostic factors Chair(s) T. de Witte (Nijmegen, The Netherlands)

08:30-10:00 Westendhalle II, Marriott Hotel Chronic myeloproliferative Disorders: Biology and Treatment Chair(s) D. Lutz (Linz, Austria) , A. Barbui (Bergamo, Italy)

08:30-10:00 Illusion I-III, Messe Congress Center Anemia and iron Metabolism Chair(s) D.G. Rund (Jerusalem, Israel) , D. Loukopoulos (Athens, Greece)

08:30-10:00 Spektrum I-II, Messe Congress Centre Angiogenesis and Platelets Chair(s) K. Alitalo (Helsinki, Finland) , M. Vasa (Frankfurt Am Main, Germany)

08:30-10:00 Fantasie I-II, Messe Congress Center Molecular Mechanisms of Malignancies Chair(s) O.G. Ottmann (Frankfurt, Germany) , S.G. Santini (Genova, Italy)

10:15-11:00 Harmonie I, Messe Congress Center Transfusion Medicine Chair(s) K. Lechner (Dept. of Internal Medicine,, Austria)

10:15-11:00 Harmonie II, Messe Congress Center Molecular targeting with Inhibitors in acute and chronic Leukemias Chair(s) L. Degos (Paris, France)

10:15-11:00 Illusion I-III, Messe Congress Center Cord Blood Transplantation Chair(s) W. Arcese (Rome, Italy)

10:15-11:00 Spektrum I-II, Messe Congress Centre Haploidentical BMT in Adults and Children Chair(s) R. Powles (Sutton, United Kingdom)

10:15-11:00 Fantasie I-II, Messe Congress Center Gene Therapy Chair(s) C. Huber (Mainz, Germany)

11:15-12:30 Harmonie II, Messe Congress Center Multiple Myeloma: Treatment Results and prognostic Factors Chair(s) G. Gaidano (Novara, Italy) , P. Sonneveld (Rotterdam, The Netherlands)

11:15-12:30 Westendhalle I, Marriott Hotel CML: Prognostic Factors and Stem Cell Transplantation Chair(s) J.M. Goldman (London, United Kingdom) , A. Hochhaus (Mannheim, Germany)

11:15-12:30 Harmonie I, Messe Congress Center Stem Cell Transplantation: Clinical Studies Chair(s) J. Sierra (Barcelona, Spain) , H. Martin (Frankfurt Am Main, Germany)

11:15-12:30 Westendhalle II, Marriott Hotel Chronic lymphoproliferative Disorders: Biology Chair(s) G.A. Pangalis (Athens, Greece) , L. Bergmann (Frankfurt, Germany)

11:15-12:30 Illusion I-III, Messe Congress Center Non-Hodgkin's Lymphoma: Biology Chair(s) S. Amadori (Rome, Italy) , A. Engert (Köln, Germany)

11:15-12:30 Spektrum I-II, Messe Congress Centre Molecular Targeting and Gene Therapy Chair(s) J. Bueren (Madrid, Spain) , M. Cavazzana-Calvo (Paris, France)

11:15-12:30 Fantasie I-II, Messe Congress Center Gene regulations, Cell cycle and Apoptos-is I Chair(s) A. Biondi (Monza, Italy) , R. Delwel (Rotterdam, The Netherlands)

12:15-13:15 Harmonie I, Messe Congress Center "Is there a Role for Marrow-ablative Treatment in Follicular Non-Hodgkin's Lymphoma?" Chair(s) G.A. Pangalis (Athens, Greece)

12:15-13:15 Spektrum I-II, Messe Congress Centre Duration of anticoagulent Therapy: short or long? Chair(s) Rosendaal (Leiden, The Netherlands)

13:45-14:15 Harmonie I, Messe Congress Center EHA Business Meeting

14:15-15:45 Harmonie I, Messe Congress Center Plenary Session 1: Novel Treatment Approaches Chair(s) J. Vermylen (Leuven, Belgium) , D. Hoelzer (Frankfurt / Main, Germany)

16:00-17:00 Harmonie I, Messe Congress Center Presidential Symposium_ENTER_Best abstracts Chair(s) D. Hoelzer (Frankfurt / Main, Germany) , L. Degos (Paris, France)

17:00-18:30 ALL: Diagnosis and Biology

17:00-18:30 ALL: Treatment and Prognostic factors

17:00-18:30 AML: Biology and Molecular Genetics

17:00-18:30 AML: Diagnosis and Clinical Characteristics

17:00-18:30 AML: Treatment

17:00-18:30 AML: Prognostic factors

17:00-18:30 APL

17:00-18:30 MDS: Biology and molecular Genetics

17:00-18:30 MDS: Diagnosis and Clinical Characteristics

17:00-18:30 MDS: Treatment and prognostic Factors

17:00-18:30 Cytopenias

17:00-18:30 Infections

17:00-18:30 NHL: Biology and molecular Genetics

17:00-18:30 NHL: Diagnosis and Clinical Characteristics

17:00-18:30 NHL: Conventional Treatment

17:00-18:30 NHL: Antibody Treatment

17:00-18:30 NHL: Prognostic Factors and Outcome

17:00-18:30 NHL: Unusual Manifestations

17:00-18:30 M. Hodgkin: Biology, Treatment and prognostic Factors

17:00-18:30 Immunotherapy/Immunobiology

17:00-18:30 Stem Cell Biology Chair(s) D. Zipori (Rehovot, Israel) , K. Geissler (Vienna, Austria)

17:00-18:30 Thrombosis and Coagulation: Coagulation disorders

17:00-18:30 Thrombosis and Coagulation: Thrombotic disorders

17:00-18:30 Thrombosis and Coagulation: Laboratory analysis

17:00-18:30 Thrombosis and Coagulation: Platelets and ITP

17:00-18:30 Transfusion Medicine

Sunday, 24 June 2001

08:30-10:00 Harmonie I, Messe Congress Center Non-Hodgkin's and Hodgkin's Lymphoma: Clinical Studies Chair(s) J. Walewski (Warszawa, Poland) , L. Trümper (Göttingen, Germany)

08:30-10:00 Harmonie II, Messe Congress Center Stem Cell Transplantation: Complications Chair(s) J.J. Cornelissen (Rotterdam, The Netherlands) , B. Sirohi (Sutton, United Kingdom)

08:30-10:00 Westendhalle I, Marriott Hotel Supportive Care and Quality of Life Chair(s) B. Mansouri Taleghani (Bern, Switzerland) , J.P. Marie (Paris, France)

08:30-10:00 Illusion I-III, Messe Congress Center Acute Lymphoblastic Leukemia Chair(s) R. Bassan (Bergamo, Italy) , M. Schrappe (Hannover, Germany)

08:30-10:00 Westendhalle II, Marriott Hotel Molecular Genetics and Minimal residual Disease Chair(s) J. Gabert (Marseille, France) , M. Kneba (Goettingen, Germany)

08:30-10:00 Spektrum I-II, Messe Congress Centre Immunobiology Chair(s) J.H.F. Falkenburg (Leiden, Nederland) , M. Theobald (Mainz, Germany)

08:30-10:00 Fantasie I-II, Messe Congress Center Stem Cells (haematopoietic and non-haematopoietic) Chair(s) D. Zipori (Rehovot, Israel) , E. Lauret (Villejuif, France)

10:15-11:00 Harmonie I, Messe Congress Center Treatment of Elderly NHL Patients Chair(s) A. Hagenbeek (Utrecht, The Netherlands)

10:15-11:00 Harmonie II, Messe Congress Center Update on non-myeloablative allogeneic Transplantation: Registry Results Chair(s) A. Bacigalupo (Genova, Italy)

10:15-11:00 Spektrum I-II, Messe Congress Centre Transplantation in MDS Chair(s) F. Frassoni (Genova, Italy)

10:15-11:00 Conclusio I-II, Messe Congress Center Special Lecture Bioethics Chair(s) J.M. Goldman (London, United Kingdom)

10:15-11:00 Fantasie I-II, Messe Congress Center Microenvironment and Cell Adhesion Chair(s) D. Zipori (Rehovot, Israel)

10:15-11:00 Illusion I-III, Messe Congress Center Immunotherapy Approaches Chair(s) R. Foa (Rome, Italy)

11:00-11:30 Harmonie II, Messe Congress Center Jose Carreras Lecture Chair(s) B. Lowenberg (Rotterdam, The Netherlands) , J. Goldman (London, United Kingdom)

11:30-12:30 Harmonie I, Messe Congress Center AML: Clinical Studies Chair(s) A. Ganser (Hannover, Germany) , H. Dombret (Paris, France) , P. Feneaux (Lille, France)

11:30-12:30 Harmonie II, Messe Congress Center Chronic lymphoproliferative Disorders: Treatment Results and prognostic Factors Chair(s) R. Foa (Rome, Italy) , M. Hallek (München, Germany)

11:30-12:30 Westendhalle I, Marriott Hotel STI571 in CML and ALL Chair(s) B. Druker (Portland, United States of America) , T. Fischer (Mainz, Germany)

11:30-12:30 Illusion I-III, Messe Congress Center Multiple Myeloma: Biology Chair(s) H.S.T. Mellstedt (Stockholm, Sweden) , I. Riet van (Brussel, Belgium)

11:30-12:30 Westendhalle II, Marriott Hotel Stem Cell Transplantation: Biology Chair(s) M. Aglieta (Candiolo (to), Italy) , H. Roelofs (Leiden, The Netherlands)

11:30-12:30 Spektrum I-II, Messe Congress Centre Haemophilia and Coagulation Disorders Chair(s) P.M. Mannucci (Milan, Italy) , I. Scharrer (Frankfurt Am Main, Nederland)

11:30-12:30 Fantasie I-II, Messe Congress Center Gene Regulation, Cell Cycle and Apoptos-is II Chair(s) H. von Melchner (Frankfurt, Germany) , S.R. Frankel (New Jersey, United States of America)

11:30-12:30 SCT: Stem Cell Mobilisation and Harvest

11:30-12:30 SCT: Engraftment

11:30-12:30 SCT: Stem cell processing and experimental BMT

11:30-12:30 SCT: Sllogeneic SCT

11:30-12:30 SCT: Dose reduced SCT

11:30-12:30 SCT: Autologous SCT

11:30-12:30 SCT Complications: GVHD

11:30-12:30 SCT Complications: Infections

11:30-12:30 SCT Complications: Other

11:30-12:30 Cytogenetics and Molecular Diagnosis

11:30-12:30 Minimal Residual Diseases

12:45-14:15 Harmonie I, Messe Congress Center Plenary Session 2: New Promises of Stem Cells Chair(s) W.E. Fibbe (Leiden, The Netherlands) , E. Montserrat (Barcelona, Spain)